-
Latest evacuee from hantavirus-hit cruise lands in Europe
-
Rubio meets US pope in bid to ease tensions
-
Women linked to IS fighters return to Australia from Middle East
-
Shell profit jumps as Mideast war fuels oil prices
-
Oil sinks, Tokyo leads Asia stock surge on growing Mideast peace hopes
-
India vows to crush terror 'ecosystem', a year after Pakistan conflict
-
Circus tackles jihadist nightmares of Burkina Faso's children
-
Iran denies ship attack as Trump warns of renewed bombing, eyes deal
-
Badminton looks to future with 'evolution and innovation'
-
Troubled waters: Jakarta battles deadly, invasive suckerfish
-
Senegal's children mourn in silence when migrant parents disappear
-
EU weighs options as summer jet fuel threat looms
-
Spurs thrash Timberwolves as Knicks edge Sixers in NBA playoffs
-
Australia to force gas giants to reserve fuel for domestic use
-
AirAsia signs $19bn deal for 150 Airbus A220 jets
-
Japan fires missiles during drills, drawing China rebuke
-
Toluca rout Son's LAFC to set up all-Mexican CONCACAF final
-
Vingegaard begins bid for Giro-Tour double with Pellizzari boosting home hopes
-
Roma's Champions League return back on as Milan, Juve wobble
-
Tokyo leads Asia stock surge on growing Mideast peace hopes
-
Australia cricket great Warner to 'accept' drink-drive charge: lawyer
-
Brunson steers Knicks to 2-0 lead with tight win over Sixers
-
Rubio seeks to ease tensions with US pope
-
AI disinfo tests South Korean laws ahead of local elections
-
Australian state overturns Melbourne ban on World Cup watch party
-
Colombian ex-fisherman swaps trade for saving Caribbean coral
-
Lobito Corridor: Africa's mega-project facing delivery test
-
Africa's Lobito Corridor chief tells AFP business, not geopolitics, drives strategy
-
Trump to host Lula in test of fitful relationship
-
K-pop stars BTS draw 50,000-strong crowd in Mexico
-
Britons set to punish Starmer's Labour in local polls
-
Wars in Middle East, backyard loom over ASEAN summit
-
US court releases purported Epstein suicide note
-
Israeli court rejects flotilla activists' appeal challenging detention
-
Victim's lawyer alleges Boeing was 'negligent' in 2019 Ethiopian crash
-
Williamson named in New Zealand squad for Ireland, England Tests
-
PSG add muscle to magic as another Champions League final beckons
-
Tigers' pitcher Valdez suspended for hitting opponent
-
Trump says Iran deal 'very possible' but threatens strikes if talks fail
-
Musk's SpaceX strikes data center deal with Anthropic
-
Bayern lament lack of 'killer' instinct after PSG elimination
-
Virus-hit cruise ship heads for Spain as evacuees land in Europe
-
Holders PSG edge Bayern Munich to reach Champions League final
-
Russia warns diplomats in Kyiv to evacuate in case of strike
-
Hantavirus ship passenger: 'They didn't take it seriously enough'
-
First hantavirus infection could not have been during cruise: WHO expert
-
Kentucky Derby-winner Golden Tempo to skip Preakness Stakes
-
Trump says Iran deal 'very possible', but threatens strikes if not
-
Lula heads to Washington to meet Trump in fraught election year
-
No timeline for injury return for 'frustrated' Doncic
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
D.Schneider--BTB